Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

988 results about "Enol" patented technology

Enols, or more formally, alkenols, are a type of reactive structure or intermediate in organic chemistry that is represented as an alkene (olefin) with a hydroxyl group attached to one end of the alkene double bond. The terms enol and alkenol are portmanteaus deriving from "-ene"/"alkene" and the "-ol" suffix indicating the hydroxyl group of alcohols, dropping the terminal "-e" of the first term. Generation of enols often involves removal of a hydrogen adjacent (α-) to the carbonyl group—i.e., deprotonation, its removal as a proton, H⁺. When this proton is not returned at the end of the stepwise process, the result is an anion termed an enolate (see images at right). The enolate structures shown are schematic; a more modern representation considers the molecular orbitals that are formed and occupied by electrons in the enolate. Similarly, generation of the enol often is accompanied by "trapping" or masking of the hydroxy group as an ether, such as a silyl enol ether.

Process for the synthesis of unsaturated alcohols

A process of preparing an unsaturated alcohol (olefin alcohol), such as, a homo-allylic mono-alcohol or homo-allylic polyol, involving protecting a hydroxy-substituted unsaturated fatty acid or fatty acid ester, such as methyl ricinoleate, derived from a seed oil, to form a hydroxy-protected unsaturated fatty acid or fatty acid ester; homo-metathesizing or cross-metathesizing the hydroxy-protected unsaturated fatty acid or fatty acid ester to produce a product mixture containing a hydroxy-protected unsaturated metathesis product; and deprotecting the hydroxy-protected unsaturated metathesis product under conditions sufficient to prepare the unsaturated alcohol. Preferably, methyl ricinoleate is converted by cross-metathesis or homo-metathesis into the homo-allylic mono-alcohol 1-decene-4-ol or the homo-allylic polyol 9-octadecene-7,12-diol, respectively.
Owner:DOW GLOBAL TECH LLC

Methods of making non-transgenic herbicide resistant plants

The present invention relates to the production of a non-transgenic plant resistant or tolerant to a herbicide of the phosphonomethylglycine family, e.g., glyphosate. The present invention also relates to the use of a recombinagenic oligonucleobase to make a desired mutation in the chromosomal or episomal sequences of a plant in the gene encoding for 5-enol pyruvylshikimate-3-phosphate synthase (EPSPS). The mutated protein, which substantially maintains the catalytic activity of the wild-type protein, allows for increased resistance or tolerance of the plant to a herbicide of the phosphonomethylglycine family, and allows for the substantially normal growth or development of the plant, its organs, tissues or cells as compared to the wild-type plant irrespective of the presence or absence of the herbicide.
Owner:CIBUS

Semi-synthetic terephthalic acid via microorganisms that produce muconic acid

The invention provides a non-naturally occurring microbial organism having a muconate pathway having at least one exogenous nucleic acid encoding a muconate pathway enzyme expressed in a sufficient amount to produce muconate. The muconate pathway including an enzyme selected from the group consisting of a beta-ketothiolase, a beta-ketoadipyl-CoA hydrolase, a beta-ketoadipyl-CoA transferase, a beta-ketoadipyl-CoA ligase, a 2-fumarylacetate reductase, a 2-fumarylacetate dehydrogenase, a trans-3-hydroxy-4-hexendioate dehydratase, a 2-fumarylacetate aminotransferase, a 2-fumarylacetate aminating oxidoreductase, a trans-3-amino-4-hexenoate deaminase, a beta-ketoadipate enol-lactone hydrolase, a muconolactone isomerase, a muconate cycloisomerase, a beta-ketoadipyl-CoA dehydrogenase, a 3-hydroxyadipyl-CoA dehydratase, a 2,3-dehydroadipyl-CoA transferase, a 2,3-dehydroadipyl-CoA hydrolase, a 2,3-dehydroadipyl-CoA ligase, a muconate reductase, a 2-maleylacetate reductase, a 2-maleylacetate dehydrogenase, a cis-3-hydroxy-4-hexendioate dehydratase, a 2-maleylacetate aminoatransferase, a 2-maleylacetate aminating oxidoreductase, a cis-3-amino-4-hexendioate deaminase, and a muconate cis / trans isomerase. Other muconate pathway enzymes also are provided. Additionally provided are methods of producing muconate.
Owner:GENOMATICA INC

Catalyst used in ring-opening hydrogenation reaction of furan derivative

The invention relates to a catalyst used in a ring-opening hydrogenation reaction of a furan derivative. The catalyst is applied to direct preparation of one-step ring-opening hydrogenation of 1,5-pentanediol and 1,2-pentanediol by taking furfural or furfuryl alcohol serving as a raw material under a mild condition. The catalyst can provide two active ingredients, namely the ring-opening active center of a transition metal oxide and the hydrogenation active center of Pt, Pd, Rh, Ru, Co or Ni, wherein the active center of the transition metal oxide is mainly used for adsorbing furfural or furfuryl alcohol and directly hydrogenating a furan ring for opening the furan ring; and the hydrogenation active center of a noble metal or Co, Ni and the like is mainly used for quickly hydrogenating an intermediate material and hydrogenating subsequent enol so as to obtain 1,5-pentanediol and 1,2-pentanediol. An environmentally-friendly, reproducible, low-cost, mild and effective method is provided for producing 1,5-pentanediol and 1,2-pentanediol. The high-performance ring-opening hydrogenation catalyst is also suitable for the ring-opening hydrogenation reaction of other furan derivatives.
Owner:EAST CHINA UNIV OF SCI & TECH

Water-based mortar modifier, its preparation method and application

The invention discloses a water-based mortar modifier, its preparation method and application. The modifier comprises the following preparation raw materials by mass: 10-20% of polyether polycarboxylic acid water reducing agent, 0.1-10% of air entraining components, 1-20% of coagulation retarding components, 0.1-2% of water retention components and 60-85% of water. The polyether polycarboxylic acid water reducing agent is prepared by the method of: dissolving an enol polyether macromonomer, acrylic acid, and maleic anhydride in water, conducting heating to raise the temperature to 60-70DEG C, then adding a persulfate water solution dropwisely, carrying out heat preservation under 60-65DEG C for 2-4h, then performing cooling to a temperature of 45DEG C, and adjusting the pH value of the system to 7-8, thus obtaining the polyether polycarboxylic acid water reducing agent. The modifier provided in the invention can form a protective film on a cement particle surface, and at the same time can produce uniform and tiny bubbles, as well as reduce the friction between the particles in the system, thus effectively improving the workability and plasticity of the mortar system. Furthermore, the mortar modifier provided in the invention is a water-based multifunctional building mortar modifier, and is convenient to use. Doping of the modifier can significantly improve the workability and vicidity of mortar, and can maintain the properties effectively for 8-16 hours.
Owner:GUANGZHOU CHEM CO LTD CHINESE ACADEMY OF SCI

Non-transgenic herbicide resistant plants

The present invention relates to the production of a non-transgenic plant resistant or tolerant to a herbicide of the phosphonomethylglycine family, e.g., glyphosate. The present invention also relates to the use of a recombinagenic oligonucleobase to make a desired mutation in the chromosomal or episomal sequences of a plant in the gene encoding for 5-enol pyruvylshikimate-3-phosphate synthase (EPSPS). The mutated protein, which substantially maintains the catalytic activity of the wild-type protein, allows for increased resistance or tolerance of the plant to a herbicide of the phosphonomethylglycine family, and allows for the substantially normal growth or development of the plant, its organs, tissues or cells as compared to the wild-type plant irrespective of the presence or absence of the herbicide. The present invention also relates to a non-transgenic plant cell in which the EPSPS gene has been mutated, a non-transgenic plant regenerated therefrom, as well as a plant resulting from a cross using a regenerated non-transgenic plant having a mutated EPSPS gene. The amino acids at the positions 126, 177, 207, 438, 479, 480 and / or 505 are changed tp produce a mutant EPSPS gene product.
Owner:VALIGEN US

Empoasca vitis gothe attractant and application method thereof

The invention provides a novel empoasca vitis gothe attractant formula and application of the novel empoasca vitis gothe attractant. The application method comprises the following steps: mainly preparing the attractant by the following components including tea tree volatile matters trans-2-hexenal, cis-3-hexene-1-ol and cis-3-hexenyl acetate, geraniol, linalool and trans-ocimene as components of the attractant and an additional antioxidant 2, 6-butylated hydroxytoluene (BHT) in a weight ratio of (0.5-5.0):(10-20):(1.0-15):(5.0-15):(30-40):(1.0-15):(1.0-10); loading the attractant on a silicone rubber head to prepare a lure; and embedding the lure on a yellow sticky colored card to form a trap of empoasca vitis gothe. Imago of empoasca vitis gothe is trapped in a stable stage of trapping, preventing and treating the empoasca vitis gothe, so that the quantity of the empoasca vitis gothe can be effectively restricted. Researches show that the lure with the novel empoasca vitis gothe attractant can obviously enhance the trapping and killing effects of a single yellow sticky colored card, the lasting trapping capacity of the trap to the empoasca vitis gothe can be remarkably improved, the service period of the trap is remarkably prolonged, and use of chemical pesticides in the tea garden is remarkably reduced and cancelled. The attractant applied to the tea garden has the advantages of convenience in use, safety, greenness and no pollution and meets the national green prevention and control principle, thereby accelerating the industrial development of organic tea gardens.
Owner:GUIZHOU UNIV

Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions

This invention is directed to a method of using a therapeutic composition comprising a compound of an alpha-ketoalkanoic acid (pyruvate) and / or its derivatives for the treatment of cytokine-mediated inflammatory conditions. The compound is an alpha-ketoalkanoic acid, a physiologically acceptable salt of an alpha-ketoalkanoic acid, an ester of an alpha-ketoalkanoic acid, or an amide of an alpha-ketoalkanoic acid. A component for inducing and stabilizing the enol resonance form of the ester at physiological pH values is also disclosed. The cytokine-mediated inflammatory conditions are mediated by, for example, an “early” (Tumor Necrosis Factor (TNF), interleukin-1β (IL-1β)) or “late” (high mobility group B-1 (HMGB-1)) mediator of inflammation. Exemplary cytokine-mediated inflammatory conditions include, but are not limited to, local and systemic inflammation, inflammatory bowel disease (Crohn's disease and ulcerative colitis), rheumatoid arthritis, asthma (including status asthmaticus), sepsis or septic shock, also including inflammatory skin conditions, for example, psoriasis and eczema.
Owner:NORTH SHORE LONG ISLAND JEWISH RES INST +1

Stimuli-responsive polymer utilizing keto-enol tautomerization and stimuli-responsive separating material and chemical-releasing capsule comprising the same

A stimuli-responsive polymer derivative utilizing keto-enol tautomerization. Also disclosed are a simple process for producing an N-acyl(meth)acrylamide derivative which can be used as a monomer for the stimuli-responsive polymer, a process for the production of an intermediate thereof, and an intermediate thus produced.
Owner:JNC CORP

Dihydroxy enol compounds used in chemical mechanical polishing compositions having metal ion oxidizers

A chemical mechanical polishing composition contains 1) water, 2) optionally an abrasive material, 3) an oxidizer, preferably a per-type oxidizer, 4) a small amount of soluble metal-ion oxidizer / polishing accelerator, a metal-ion polishing accelerator bound to particles such as to abrasive particles, or both; and 5) at least one of the group selected from a) a small amount of a chelator, b) a small amount of a dihydroxy enolic compound, and c) a small amount of an organic accelerator. Ascorbic acid in an amount less than 800 ppm, preferably between about 100 ppm and 500 ppm, is the preferred dihydroxy enolic compound. The polishing compositions and processes are useful for substantially all metals and metallic compounds found in integrated circuits, but is particularly useful for tungsten. The present invention also pertains to surface-modified colloidal abrasive polishing compositions and associated methods of using these compositions, particularly for chemical mechanical planarization, wherein the slurry comprises low levels of chelating free radical quenchers, non-chelating free radical quenchers, or both.
Owner:VERSUM MATERIALS US LLC

Production of opioid analgesics

The present invention includes a process for the manufacture of dihydrothebaine, dihydrocodeinone enol acetate, hydrocodone, and analogs thereof by reacting dihydrocodeine or analogs thereof with benzophenone in the presence of potassium tert-alkylate in a hydrocarbon solvent to generate a reaction mixture containing an enolate of the corresponding ketone, followed by addition of the reaction mixture to the electrophilic agent and isolation of the product.
Owner:ACURA PHARMA

Polycarboxylate-type water reducing agent suitable for mud-containing aggregates and preparation method therefor

ActiveCN103641963AShield adsorptionGuarantee water reduction and slump protectionCarboxylic acidWater reducer
The invention discloses a preparation method for a polycarboxylate-type water reducing agent suitable for mud-containing aggregates and belongs to the water reducing agent field. First, nonsaturated monocarboxylic acid and derivatives thereof, and / or nonsaturated dicarboxylic acid and derivatives thereof, phosphorus-containing monomers, and 2-acrylamide-2-methyl propanesulfonic acid (AMPS) are subjected to copolymerization under action of initiators and a kind of phosphono carboxylic acid copolymers are obtained; then the obtained phosphono carboxylic acid copolymers, isoamyl enol polyethenoxy ether, tetrabutyl ammonium fluoride, nonsaturated monocarboxylic acid and derivatives thereof are subjected to free radical copolymerization under action of initiators and chain transferring agents and the polycarboxylate-type water reducing agent is obtained. The adsorption of high valent metal ions to the polycarboxylate-type water reducing agent can be reduced, the adverse influences of the mud content of aggregates in concrete to the polycarboxylate-type water reducing agent can be avoided, and the problems of insufficient water reducing of concrete, low intensity and the like can be solved without raising mixing amount of the polycarboxylate-type water reducing agent.
Owner:NANJING RUIDI HIGH TECH

Process for preparing corosolic acid and crataegolic acid

InactiveCN1634971ASimple and efficient synthesisAvoid steric hindranceSteroidsAnti virusCorosolic acid
Disclosed are preparing processes for industrialized application of Corosolic acid with blood sugar lowering, weight reducing, anti-tumor and anti-inflammatory actions and maslinic acid with anti-tumor, anti-virus and cardiovascular diseases resistant actions. The processes include respectively preparing Corosolic acid and maslinic acid using 3-carbonyl ursolic acid ester and 3-carbonyl oleanolic acid ester by acid catalysed enolization esterification reaction, hydroboration oxidation reaction, catalytic hydrogenolysis reaction and haloidlysis reaction.
Owner:CHINA PHARM UNIV

Antistatic surface protection film

ActiveCN104774569ASuppresses peeling static voltageLow agingLamination ancillary operationsNon-macromolecular adhesive additivesAntistatic agentKetone
The invention provides an antistatic surface protection film, the pollution to a pasted body is light, and the antistatic surface protection film is provided with excellent anti-stripping electrostatic properties without time dependent degradation. The antistatic surface protection film is formed in a way that a binder layer (2) composed of a binder composition is formed on one side of a base film (1) formed by a transparent resin, the binder composition comprises an acrylate-based polymer containing copolymers, (F) an isocyanate compound containing more than two functional groups, (G) a crosslinking accelerator and (H) a ketone-enol tautomer compound, a stripping agent layer (4) containing an antistatic agent is laminated on one side of a resin film (3) to form a stripping film (5), and the stripping film (5) is attached to the surface of the binder layer (2) through the stripping agent layer (4). The stripping agent layer (4) is formed by a resin composition, and the resin composition comprises a stripping agent taking dimethyl polysiloxane as the key component, a polysiloxane compound which is liquid under 20 DEG C and an antistatic agent, and the stripping electrostatic pressure of the binder layer (2) is lower than + / -0.6kV.
Owner:FUJIMORI KOGYO CO LTD

EPSPS mutants

The present invention relates to the production of a non-transgenic plant resistant or tolerant to a herbicide of the phosphonomethylglycine family, e.g., glyphosate. The present invention also relates to the use of a recombinagenic oligonucleobase to make a desired mutation in the chromosomal or episomal sequences of a plant in the gene encoding for 5-enol pyruvylshikimate-3-phosphate synthase (EPSPS). The mutated protein, which substantially maintains the catalytic activity of the wild-type protein, allows for increased resistance or tolerance of the plant to a herbicide of the phosphonomethylglycine family, and allows for the substantially normal growth or development of the plant, its organs, tissues or cells as compared to the wild-type plant irrespective of the presence or absence of the herbicide. Additionally the present invention relates to mutant E. coli cells that contain mutated EPSPS genes.
Owner:CIBUS

Synthesis process of vecuronium bromide

The invention discloses a synthesis process of vecuronium bromide. The synthesis process comprises the following steps: generating epiandrosterone sulfonyl ester (III) by carrying out esterification reaction between epiandrosterone (II) and paratoluensulfonylchloride; generating 5Alpha-androst-2-alkene-17-ketone (IV) by carrying out elimination and dehydration reaction between the (III) and 2,6-lutidines; generating 17-acetoxyl-5Alpha-androstane-2,16-diene (V) by carrying out enolization and esterification reaction between the (IV) and isopropenyl acetate; generating (2Alpha, 3Alpha, 16Alpha,17Alpha)-diepoxy-17Beta-acetyl-5Alpha-androstane (VI) by epoxy reaction of the (V) under the effect of hydrogen peroxide; generating 2Beta, 16Beta-di(1-piperidyl)-5Alpha-androstane-3Alpha-hydroxyl-17-ketone (VII) by ring-opening and addition reaction of the (VI) under the effect of hexahydropyridine; generating 2Beta, 16Beta-di(1-piperidyl)-5Alpha-androstane-3Alpha,17Beta-diol (VIII) by the (VII)under the reduction of potassium borohydride; generating 2Beta, 16Beta-di(1-piperidyl)-3Alpha, 17Beta- acetoxyl-5Alpha-androstane (IX) by carrying out esterification reaction of the (VIII) under the acetylation of acetic anhydride; and generating vecuronium bromide (I) by carrying out quaternary ammonium salt reaction between the (IX) and bromomethane. The invention has the advantages of low cost,less pollution and high yield.
Owner:XUZHOU NORMAL UNIVERSITY

Industrial production method for prasugrel

The invention relates to the technical field of a preparation method of an antithrombotic drug Prasugrel. The preparation method utilizes the existing cyclopropyl-2- fluoro-benzylone which is treated with enol esterification, oxidization, sulfonylation, condensation and synthesis to obtain the Prasugrel. Compared with the prior art, the preparation method provided by the invention has low toxicity in raw materials and reagents used, low requirements in labor protection, low prices of and easy access to raw materials and reagents, less emission of three wastes (waste gas, waste water and waste residues), less pollution to the environment and no corrosion to equipment during the production; simultaneously, the preparation method also has simple operation and greater yield compared with the prior art and is applicable to industrial mass production.
Owner:SHANGHAI SHYNDEC PHARMA CO LTD +1

Method of catalyzed oxidation of olefin to produce enol, ketenes and epoxy compound

According to the present invention, the oxidation agent uses air or oxygen, or mixture gas of oxygen and inert gas, or other chemical oxidation agent, the reaction pressure is controlled to be 1-10 atm, the temperature being 20-150 deg. C, mu-oxygen single metalloporphyrin or double metalloporphyrin, or their carrier is separately selected as catalyst, or they form composite catalyst along with filtering metallic salts or oxidants, the catalyst concentration being 1-50PPM, reaction time being 0.5-5 hours, thus alpha, beta-enol, alpha, beta-ketene and epoxy compounds are obtained through catalytic oxidation of olefin or cyclomonoolefin.
Owner:HUNAN UNIV

Novel anti-tumor application of penicillium enol A1 from penicillium citrinum

The invention relates to novel anti-tumor application of an alkaloid compound penicillium enol A1 from penicillium citrinum. The penicillium citrinum IBPT-5 is collected in the China Center for Type Culture Collection (CCTCC), which is located in Wuhan University and has the collection number of CCTCC NO:M2013713, on December 25, 2013. Experiments prove that the compound has better anti-tumor activity on various tumor cells, and can be used for preparing cell proliferation inhibition medicines or anti-tumor medicines for anti-tumor study, wherein tumor cells comprise human colon cancer cells SW620, human hepatoma cells Huh7, human gastric carcinoma cells BGC-823, human colon cancer cells SW480, human esophageal squamous carcinoma cells KYSE450, human esophageal cancer cells EC9706, human highly metastatic lung carcinoma cells 95-D, human hepatoma cells PLC and human gastric carcinoma cells HGC-27.
Owner:FUZHOU UNIV

3-o-methylphenyl-2-oxo-1-oxaspiro[4,4]-n-3-ene-4-alcohol and derivatives thereof

The invention relates to 3-omethylphenyl-2-oxo-1-oxaspiro [4,4]-n-3-ene-4-alcohol which has a formula (I), derivatives and isomers thereof as well as preparation methods of the 3-omethylphenyl-2-oxo-1-oxaspiro [4,4]-n-3-ene-4-alcohol and the derivatives and the isomers thereof. The 3-omethylphenyl-2-oxo-1-oxaspiro [4,4]-n-3-ene-4-alcohol has the bioactivities of insect killing, mite killing and fungus killing.
Owner:HUNAN CHEM RES INST

Catalyst for preparing polycarboxylate water reducing agent macromonomer and preparation method thereof

The invention discloses a catalyst for preparing a polycarboxylate water reducing agent macromonomer, which is a methallyl alcohol solution of sodium methallyl alcohol or a 3-methyl-3-butene-1-alcoholic solution of 3-methyl-3-butene-1-sodium alcoholate; and the solution contains 5-20 percent by mass of sodium methallyl alcohol or 3-methyl-3-butene-1-sodium alcoholate. The preparation method comprises the following steps of: putting methallyl alcohol or 3- methyl-3-butene-1-sodium alcoholate into a reaction kettle, cutting sodium metal into small blocks, and adding into a feeding device; keeping an emptying valve in an open state and introducing nitrogen; and adding metal sodium in batch, controlling the temperature of a reaction system not to surpass 120 DEG C, closing a feed valve after the metal sodium is added, continually reacting till a reaction liquid does not produce air bubbles, closing the emptying valve, stopping introducing nitrogen, and discharging. Due to the adoption of the catalyst, byproducts are not generated in the preparation process of macromonomer methylallyl polyoxyethylene ether and prenyl polyoxyethylene ether, and the purity of the macromonomer can be effectively increased.
Owner:山西山大合盛新材料股份有限公司

Synthesis method of methyl-alpha-fluoroacrylate and analogues thereof

The invention relates to a synthesis method of methyl-alpha-fluoroacrylate and analogues thereof. The method comprises the following steps: step 1, based on methyl fluoroacrylate and dimethyl oxalate serving as raw materials, dissolving the raw materials in a solvent, and adding base for carrying out condensation reaction so as to generate sodium enolate or potassium enolate intermediate; and step 2, reacting sodium enolate or potassium enolate intermediate with paraformaldehyde or trioxane in the solvent so as to generate methyl-alpha-fluoroacrylate. According to the invention, cheap methyl fluoroacrylate and dimethyl oxalate are used as the raw materials, and the low-cost solvent and other reactants are selected, thus the method has the advantages of low preparation cost and high yield and can be suitable for large-scale industrial production.
Owner:RADIANT PHARMA & TECH

Covalent organic framework material containing beta-ketoenamine structure, and preparation method and application thereof

ActiveCN110229345ARich porosityRegular and ordered pore structureKetoneCrystallinity
The invention discloses a covalent organic framework material containing a beta-ketoenamine structure, and a preparation method and an application thereof. The covalent organic framework material hasa pyrene structural unit and the beta-ketoenamine structure. The preparation method comprises the following steps: uniformly mixing pyrenyl diphenylamine and 2,4,6-triformyl pyrogallol in an organic solvent, adding a weakly-acidic catalyst, and carrying out a reversible Schiff base reaction and an irreversible enol-ketone tautomerization reaction under solvothermal conditions so as to obtain the covalent organic framework material containing the beta-ketoenamine structure, wherein the beta-ketoenamine structure comprises a repeated unit as shown in a formula I or a formula II which are described in the specification. The covalent organic framework material provided by the invention has the advantages of high crystallinity, porosity, regular and ordered pore channel structure, high specificsurface area, low density, good thermal stability and chemical stability, and good application prospects in the fields of gas storage and separation, catalysis, sensing, energy storage and conversion, drug delivery and the like. In the formula I and the formula II, R is one selected from the group consisting of hydrogen and C1-C20 straight-chain or branched-chain alkyl or alkoxy groups.
Owner:NANJING UNIV OF POSTS & TELECOMM

Novel anti-tumor application of penicillium enol B1 from penicillium citrinum

The invention relates to novel anti-tumor application of an alkaloid compound penicillium enol B1 from penicillium citrinum. The penicillium citrinum IBPT-5 is collected in the China Center for Type Culture Collection (CCTCC), which is located in Wuhan University and has the collection number of CCTCC NO:M2013713, on December 25, 2013. The compound has good anti-tumor activity to various tumor cells, and can be used for preparing cell proliferation inhibition medicines or anti-tumor medicines for anti-tumor study, wherein tumor cells comprise human colon cancer cells SW620, human hepatoma cells Huh7, human gastric carcinoma cells SGC-7901, human gastric carcinoma cells BGC-823, human colon cancer cells SW480, human esophageal cancer cells EC9706, human highly metastatic lung carcinoma cells 95-D, human hepatoma cells PLC, human gastric carcinoma cells HGC-27 and human lymphoma cells RAJI.
Owner:FUZHOU UNIV

Use of bacillus subtilis in degradation of deoxynivalenol

InactiveCN101412976AAvoid degradationAvoid the disadvantages of nutrient composition being destroyedBacteriaBacteria material medical ingredientsMycotoxinLiquid medium
The invention relates to application of a bacillus subtilis in the degradation of mycotoxins deoxynivalenol enol. The application method is as follows: 1. a method for eliminating the interference of a liquid medium to an indirect competitive ELISA which detects the deoxynivalenol enol; 2. a method for preparing an enzyme preparation from a strain cultured product; 3. a method for preparing a living bacteria preparation; and 4. a method for preparing an oral preparation or a drug for human body or animal body detoxification. The invention has the advantages that the bacillus subtilis can completely degrade the polluted mycotoxin deoxynivalenol enol in food or feed through biosynthesis and zymological approach under a moderate condition, and can avoid the disadvantages of incomplete degradation and destruction of nutrient caused by using a physical or a chemical method to process mycotoxin.
Owner:NANCHANG UNIV

Taxol and its analogue side chain synthesizing method

This invention has disclosed a kind of synthetic method to paclitaxol and side chain of its analogue. This invention using low-cost alpha- glycolic acid as raw material, the asymmetry addition reaction induced by chirality tertiary butyl sulfinamide as committed step, prepares paclitaxol and polyene paclitaxol side chain. The chemical product quotiety of key reaction is high, protecting group is easy to control and operate, synthesis process is short.
Owner:成都科杰高新技术发展有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products